Facing the Truth About Depo-Provera and Brain Tumors
You chose the Depo-Provera shot for convenience and safety. For years, perhaps decades, you trusted this medication to handle your reproductive health. Now, you are facing a diagnosis that has torn your world apart: a meningioma brain tumor or severe bone density loss. You might be staring at an MRI of a mass pressing against your brain tissue, or you may be struggling with the sudden, sharp pain of a fracture caused by premature osteoporosis.
We know the moment you are in. You are sitting at your kitchen table with a folder of medical records, wondering how a “safe” birth control method could lead to brain surgery. The manufacturer, Pfizer, marketed this drug as a simple, 13-week injection cycle. But emerging science and recent regulatory actions suggest that for many women, the cost of that convenience was far higher than ever disclosed.
Our trial team handles complex defective-drugs cases nationwide. We are currently investigating claims for women who used Depo-Provera for more than two years and subsequently developed intracranial meningiomas or suffered catastrophic bone loss. If you are in this crisis, you are not alone, and you are not powerless.
The Scientific Link: Why Long-Term Use Is Dangerous
The medical community is currently reeling from data that the manufacturer should have identified years ago. A landmark 2024 study published in the BMJ reported that long-term users of medroxyprogesterone acetate (the active ingredient in Depo-Provera) face a 5.6-fold increased risk of developing meningiomas compared to non-users.
A meningioma is a tumor that grows from the meninges—the protective layers surrounding the brain and spinal cord. While these tumors are often classified as “noncancerous,” that label is misleading. A mass inside the skull has nowhere to go. As it grows, it impinges on vital nerves and blood vessels, causing seizures, vision loss, hearing impairment, and cognitive decline. For many of our clients, the only “treatment” is a craniotomy—invasive brain surgery to cut the tumor out.
Beyond the brain, the drug has long been known to strip the body of essential minerals. Depo-Provera reduces estrogen levels, which are critical for maintaining bone strength. This leads to:
* Significant bone mineral density (BMD) loss.
* Premature osteoporosis.
* Fractures of the hip, spine, and femoral neck.
While a “Black Box” warning for bone loss was added in 2004, the specific link to brain tumors was not adequately addressed on U.S. labels until December 2025. This delay represents a decades-long failure to warn millions of women of a life-altering risk.
Mapping the Litigation: MDL 3140 and Pfizer’s Liability
Because injuries from this drug are occurring across the country, the legal system has consolidated these claims into Multidistrict Litigation, specifically MDL 3140. While cases are filed by women in every state, the legal epicenter for this fight is often centered in the District of New Jersey or the Southern District of New York, near the corporate headquarters where Pfizer’s decision-makers reside.
Our theory of liability against Pfizer Inc. is built on three pillars:
- Failure to Warn: The manufacturer knew, or through proper clinical testing should have known, of the meningioma risk. They failed to update the U.S. safety label for years, even as scientific signals mounted.
- Design Defect: The high-dose hormonal formulation is inherently dangerous for long-term use, especially when compared to safer contraceptive alternatives with lower risk profiles.
- Gross Negligence: We believe there was a willful disregard for patient safety by promoting a 13-week cycle that encouraged long-term dependence despite known risks of bone destruction and tumor growth.
Under product liability law, specifically the frameworks similar to New Jersey’s Products Liability Act, a manufacturer is liable if their product lacked adequate warnings. We use the discovery rule to protect your rights; in many states, the clock to file a lawsuit does not begin until you “discover” the link between the drug and your injury—often triggered by the 2024 study or the late 2025 label change.
What Is Your Depo-Provera Case Worth?
When we evaluate a wrongful-death-claim-lawyer or a catastrophic injury case involving a brain tumor, we look at the total wreckage the drug caused. Based on current litigation trends and the severity of neurosurgical intervention, we estimate case values in these ranges:
- Low Tier ($150,000 – $300,000): Cases involving significant bone mineral density loss or osteoporosis without major fractures, or small meningiomas that require monitoring but not immediate surgery.
- High Tier ($500,000 – $2,500,000+): Cases involving invasive brain surgery (craniotomy), post-operative ICU care, permanent neurological deficits like vision or hearing loss, and long-term rehabilitation.
Your recovery should include economic damages for the cost of surgery and lost earning capacity, as well as non-economic damages for the mental anguish of a brain tumor diagnosis. As your [masstort-national product liability lawyer], we work with a multidisciplinary expert panel—including neuro-oncologists, endocrinologists, and regulatory experts—to prove that the drug caused the tumor and that Pfizer failed to provide you with a fair choice.
“A manufacturer is liable if the product lacked adequate warnings or was defectively designed… punitive damages may be pursued if it can be proven the manufacturer withheld or misrepresented material safety information.” — New Jersey Products Liability Act (N.J.S.A. 2A:58C-1) and related doctrine.
The Insurance Industry Playbook: How They Fight Back
Even with clear scientific data, Pfizer and their insurance-defense teams will not simply hand over a check. They use a standard set of plays to devalue your suffering. Because our associate attorney Lupe Peña is a former insurance-defense insider, we know these tactics from the inside:
- The “Learned Intermediary” Defense: They will argue that they warned your doctor, and it was your doctor’s job—not theirs—to warn you about the two-year limit. We counter this by showing that the manufacturer’s own marketing downplayed the risks to the medical community.
- The “Pre-Existing” Play: They will scour your medical history for any other reason you might have had a headache or bone pain, trying to claim the drug was not the primary cause.
- The Statute of Limitations Trap: They will argue you waited too long to sue. We use the “discovery rule” and the timing of the December 2025 label change to prove your claim is timely.
We don’t let these tactics move through the system. We work to freeze the evidence and build a proof story that the insurance industry cannot ignore.
The Evidence Clock: Why the First 72 Hours Matter
If you suspect your injury is related to Depo-Provera, the clock is already running on the evidence we need to win.
- Pharmacy Dispensing Records: These prove how long you were on the shot and whether you received the brand-name drug or a generic. Pharmacies often purge these records after 7 to 10 years. We must secure them now.
- Diagnostic Imaging (MRI/CT): We need the digital DICOM files from your scans, not just the paper report. These prove the growth rate and location of the tumor.
- Pathology Reports: If you had surgery, the tissue samples (often stored in paraffin blocks) can confirm if the tumor is progesterone-receptor-positive, creating a direct biological link to the drug.
- Medical Prescribing Notes: We need to see what your doctor was told by the manufacturer and why they continued the injections past the two-year mark.
Why Choose Attorney911 for Your Fight?
We are not a high-volume “settlement mill.” We are a trial firm that takes the fight to the largest corporations in the world.
Ralph P. Manginello has been licensed for over 27 years. He is a member of the Texas Trial Lawyers Association and the Million Dollar Member of the Trial Lawyers Achievement Association. He treats every case like it is headed for a jury because that is the only way to get a fair result from a company like Pfizer.
Lupe Peña brings a unique advantage to our firm. He spent years inside the rooms where insurance adjusters and their software decided how to deny and devalue claims. He knows how they set their reserves and which evidence actually makes them move their numbers. Lupe is also fluent in Spanish and conducts full consultations without an interpreter. Hablamos Español.
We take these cases on a contingency fee basis. This means we don’t get paid unless we win your case. You get a free consultation and 24/7 access to live staff who can handle your legal emergency.
Steps to Take in the Next 72 Hours
- Seek Medical Monitoring: If you have used Depo-Provera for more than two years and have severe headaches, vision changes, or seizures, request an MRI immediately.
- Stop the Purge: Contact your pharmacy and request a printout of your entire prescription history.
- Do Not Sign Anything: If a representative from a pharmaceutical company or an insurance carrier contacts you, do not give a recorded statement.
- Call 1-888-ATTY-911: The day you call is the day the clock starts working for you instead of against you.
Past results depend on the facts of each case and do not guarantee future outcomes. We are here to protect you, prove what happened, and dominate the companies that put profits over patients.
Frequently Asked Questions
What happens if I took Depo-Provera for more than 2 years?
Taking the shot for more than two years is associated with significant bone mineral density loss and a 5.6-fold increased risk of developing a meningioma brain tumor. The FDA label includes a “Black Box” warning advising against use beyond two years unless other options are inadequate.
Is the brain tumor linked to Depo-Provera cancerous?
Meningiomas are typically classified as noncancerous (benign), but they are still life-threatening. Because they grow inside the skull, they compress brain tissue and often require invasive surgery to prevent permanent neurological damage.
Can I sue if I was diagnosed with osteoporosis after the shot?
Yes. If you used the drug for an extended period and were not properly warned about the risk of permanent bone loss, you may have a claim for medical expenses, pain, and suffering.
What is the statute of limitations for a Depo-Provera lawsuit?
It varies by state, but the “discovery rule” often applies. This means your time to sue may not begin until you knew (or should have known) that the drug caused your tumor or bone loss. With the recent scientific studies in 2024, the window for many women is open right now.
How much does it cost to hire a [masstort-national product liability lawyer]?
At our firm, there is no fee unless we win. We work on a contingency basis, meaning we advance all the costs of the litigation and only get paid if we secure a settlement or verdict for you.
What is MDL 3140?
MDL 3140 is the federal Multidistrict Litigation where Depo-Provera cases are being consolidated. This allows one judge to handle all the pretrial groundwork, making the process faster and more efficient for victims across the country.
What symptoms should I look for?
New research suggests watching for persistent “migraines,” vision impairment, hearing loss, seizures, or unexplained bone pain and fractures. If you have these symptoms, you should request an MRI and consult with a medical professional immediately.
Why wasn’t I warned about the brain tumor risk earlier?
Pfizer did not update the U.S. label to include a meningioma warning until December 2025. This failure to warn is the central issue in current brain-injuries litigation regarding Depo-Provera.
Does it matter if I used the generic version?
You can still pursue a claim if you used the generic form (medroxyprogesterone acetate), but the legal strategy regarding “preemption” changes. We analyze your pharmacy records to determine the correct path for your specific case.
How do I join the mass tort?
The first step is a free case review. Call us at 1-888-ATTY-911. We will help you gather your medical-malpractice and pharmacy records to see if you qualify for the ongoing mass-tort litigation.